Research Articles
Structural Divergence and Functional Specialization: A Comparative Analysis of STAT and Src-Family SH2 Domains
This article provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains found in STAT and Src-family proteins, two classes of proteins central to cellular signaling.
Navigating Selectivity: A Comprehensive Guide to Cross-Reactivity Profiling of STAT SH2 Domain Inhibitors
The development of selective inhibitors for STAT (Signal Transducer and Activator of Transcription) SH2 domains represents a promising therapeutic strategy for cancers and inflammatory diseases.
Achieving Specificity: A Comprehensive Guide to Validating STAT SH2 Domain Inhibitors Across the STAT Family
The development of specific STAT SH2 domain inhibitors represents a promising therapeutic strategy for cancers and inflammatory diseases.
Small Molecule vs. Peptidomimetic SH2 Domain Inhibitors: A Strategic Comparison for Targeted Drug Discovery
This article provides a comprehensive comparison for researchers and drug development professionals on two primary strategies for inhibiting SH2 domain-mediated protein-protein interactions: small molecules and peptidomimetics.
STAT1 vs STAT3 SH2 Domain Specificity: Structural Insights, Inhibitor Design, and Therapeutic Implications
This review provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains of STAT1 and STAT3, transcription factors critical in immunity, inflammation, and cancer.
Overcoming Compensatory Signaling in STAT Pathway Inhibition: Mechanisms and Combination Therapies
Constitutive activation of the JAK-STAT pathway is a hallmark of numerous cancers and autoimmune diseases, driving the development of targeted inhibitors.
Breaking the Barrier: Strategies for Enhancing Cellular Uptake of SH2 Domain-Targeted Therapeutics
Targeting Src Homology 2 (SH2) domains represents a promising therapeutic strategy for modulating dysregulated cell signaling in cancer and other diseases.
Mastering SH2 Domain Dynamics: Strategies for Managing Rapid Off-Rates in Phosphopeptide Interactions
This article provides a comprehensive analysis of rapid off-rates in SH2 domain-phosphopeptide interactions, a critical feature for ensuring dynamic and specific cellular signaling.
Beyond the Shallow Surface: Innovative Strategies for Targeting SH2 Domains in Drug Discovery
Targeting the shallow binding surfaces of Src Homology 2 (SH2) domains represents a significant challenge and opportunity in therapeutic development, particularly for cancer and neurodegenerative diseases.
Conquering Flexibility: Advanced Strategies for Targeting STAT SH2 Domains in Drug Design
The Signal Transducer and Activator of Transcription (STAT) proteins are critical transcription factors whose dysregulation drives numerous diseases, particularly cancer.